{"sourcedb":"DevicePMAs@therightstef","sourceid":"P010007_S002","text":"Approval for use of the immulite 2000 aft on the immulite 2500 automated analyzer.  The device, as modified, will be marketed under the trade name immulite 2500 afp and is indicated:  \"for in vitro diagnostic use with the immulite 2500 analyzers for the quantitative measurement of alpha-fetoprotein (afp) in either of two contexts: (1) serial measurements in human serum to aid in the management of patients with nonseminomatous testicular cancer; or (2) measurements in maternal serum and amniotic fluid during gestational weeks 15 through 20, used in conjunction with ultrasonography or amniography, to aid in detection of fetal open neural tube defects.\"","project":"consensus_PMA_Age_Indications"}